|
CA2407897A1
(en)
*
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
US7128911B2
(en)
|
2001-01-19 |
2006-10-31 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of bone disease
|
|
US7264810B2
(en)
*
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
US7094409B2
(en)
*
|
2001-01-19 |
2006-08-22 |
Cytos Biotechnology Ag |
Antigen arrays for treatment of allergic eosinophilic diseases
|
|
DE60234375D1
(de)
|
2001-09-14 |
2009-12-24 |
Cytos Biotechnology Ag |
VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
|
|
US7115266B2
(en)
|
2001-10-05 |
2006-10-03 |
Cytos Biotechnology Ag |
Angiotensin peptide-carrier conjugates and uses thereof
|
|
BR0311995A
(pt)
*
|
2002-06-20 |
2005-04-05 |
Cytos Biotechnology Ag |
Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
|
|
US7138252B2
(en)
*
|
2002-07-17 |
2006-11-21 |
Cytos Biotechnology Ag |
Molecular antigen arrays
|
|
CA2487849A1
(en)
|
2002-07-18 |
2004-01-29 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
EP2338510A1
(en)
*
|
2002-07-19 |
2011-06-29 |
Novartis Pharma AG |
Vaccine compositions containing amyloid beta1-6 antigen arrays
|
|
AU2004224761A1
(en)
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
HIV-peptide-carrier-conjugates
|
|
US7537767B2
(en)
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
|
EP1784210A2
(en)
*
|
2004-08-04 |
2007-05-16 |
Cytos Biotechnology AG |
Carrier conjugates of gnrh-peptides
|
|
MX2007003171A
(es)
*
|
2004-09-21 |
2007-05-23 |
Cytos Biotechnology Ag |
Particulas tipo virus que comprenden una proteina de fusion de la proteina de cubierta de ap205 y un polipeptido antigenico.
|
|
US7959928B2
(en)
*
|
2004-10-05 |
2011-06-14 |
Cytos Biotechnology Ag |
VLP-antigen conjugates and their uses as vaccines
|
|
AU2005298689A1
(en)
|
2004-10-25 |
2006-05-04 |
Cytos Biotechnology Ag |
Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
|
|
WO2006045849A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Cytos Biotechnology Ag |
T-cadherin antigen arrays and uses thereof
|
|
GB0424563D0
(en)
|
2004-11-05 |
2004-12-08 |
Novartis Ag |
Organic compounds
|
|
WO2006063974A2
(en)
*
|
2004-12-13 |
2006-06-22 |
Cytos Biotechnology Ag |
Il-15 antigen arrays and uses thereof
|
|
ZA200707413B
(en)
|
2005-03-18 |
2009-01-28 |
Cytos Biotechnology Ag |
Cat allergen fusion proteins and uses thereof
|
|
CA2608579C
(en)
*
|
2005-05-26 |
2019-09-10 |
Cytos Biotechnology Ag |
Scalable fermentation process
|
|
EP1746165A1
(en)
|
2005-07-21 |
2007-01-24 |
Cytos Biotechnology AG |
Scalable fermentation process
|
|
CN101193654A
(zh)
*
|
2005-06-14 |
2008-06-04 |
赛托斯生物技术公司 |
抗原偶联物及其用途
|
|
EP1736538A1
(en)
*
|
2005-06-21 |
2006-12-27 |
Cytos Biotechnology AG |
Process for the preparative purification of virus-like-particles (VLPs)
|
|
ES2310062B1
(es)
|
2005-07-15 |
2009-11-13 |
Bionostra, S.L. |
Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
|
|
NZ566971A
(en)
|
2005-09-28 |
2011-06-30 |
Cytos Biotechnology Ag |
Vaccine containing a virus like particle linked with an interleukin-1 molecule
|
|
WO2008037504A1
(en)
*
|
2006-09-28 |
2008-04-03 |
Cytos Biotechnology Ag |
Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases
|
|
CA2632662A1
(en)
*
|
2005-12-08 |
2007-06-14 |
South Dakota State University |
Methods of in vitro propagation and detection of infectious prion
|
|
CA2636139A1
(en)
|
2005-12-14 |
2007-06-21 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
US8541559B2
(en)
|
2006-06-12 |
2013-09-24 |
Cytos Biotechnology Ag |
Process for producing aggregated oligonucleotides
|
|
US7534595B2
(en)
*
|
2006-06-12 |
2009-05-19 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
|
US7998487B2
(en)
*
|
2007-02-16 |
2011-08-16 |
The Salk Institute For Biological Studies |
Antitoxin and vaccine platform based on nodavirus VLPs
|
|
JPWO2008133141A1
(ja)
*
|
2007-04-24 |
2010-07-22 |
東洋紡績株式会社 |
オスモチン組換えタンパク質およびその製造方法、並びにその利用
|
|
NZ583362A
(en)
|
2007-08-15 |
2012-06-29 |
Circassia Ltd |
Peptide with reduced dimer formation
|
|
US8222206B2
(en)
*
|
2008-03-04 |
2012-07-17 |
Taiwan Advance Bio-Pharm Inc. |
Method of enhancing the mobilization of hematopoietic stem cells using TAT-HOXB4H
|
|
US20110262472A1
(en)
*
|
2008-04-22 |
2011-10-27 |
Cytos Biotechnology Ag |
Vaccine compositions for the treatment of dengue fever and uses thereof
|
|
BRPI0922561A2
(pt)
|
2008-12-09 |
2020-08-11 |
Pfizer Vaccines Llc |
vacina de peptídeo de ch3 da ige.
|
|
WO2010122164A1
(en)
|
2009-04-23 |
2010-10-28 |
Cytos Biotechnology Ag |
VIRUS-LIKE PARTICLES OF BACTERIOPHAGE φCB5
|
|
NZ596058A
(en)
*
|
2009-04-30 |
2013-08-30 |
Cytos Biotechnology Ag |
Influenza hemagglutinin compositions and uses thereof
|
|
JP2013500326A
(ja)
|
2009-07-30 |
2013-01-07 |
ファイザー バクシーンズ エルエルシー |
抗原性タウペプチドおよびその使用
|
|
WO2011027257A2
(en)
|
2009-09-03 |
2011-03-10 |
Pfizer Vaccines Llc |
Pcsk9 vaccine
|
|
EP2531521B1
(en)
|
2010-02-02 |
2017-09-06 |
Amano Enzyme USA., Ltd. |
Use of proteases for gluten intolerance
|
|
EP2575868A1
(en)
|
2010-06-07 |
2013-04-10 |
Pfizer Vaccines LLC |
Ige ch3 peptide vaccine
|
|
WO2012131504A1
(en)
|
2011-03-02 |
2012-10-04 |
Pfizer Inc. |
Pcsk9 vaccine
|
|
KR20140050698A
(ko)
|
2011-07-29 |
2014-04-29 |
셀렉타 바이오사이언시즈, 인크. |
체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
|
|
CN104011080B
(zh)
|
2011-12-22 |
2017-10-20 |
弗·哈夫曼-拉罗切有限公司 |
用于真核细胞的全长抗体展示系统及其用途
|
|
ES3011307T3
(en)
|
2012-02-23 |
2025-04-07 |
Juno Therapeutics Gmbh |
Chromatographic isolation of cells and other complex biological materials
|
|
US12218609B2
(en)
*
|
2012-05-11 |
2025-02-04 |
The Regents Of The University Of California |
Virus-based piezoelectric energy generation
|
|
DE102013105144A1
(de)
*
|
2013-05-17 |
2014-11-20 |
Arno Thaller |
Pharmazeutisches Kombinationspräparat mit einem anti-idiotypischen Antikörperfragment
|
|
US10195257B2
(en)
|
2013-07-28 |
2019-02-05 |
Qantu Therapeutics, Inc. |
Vaccine formulations comprising quillaja desacylsaponins and beta amyloid peptides or tau protein to induce a Th2 immune response
|
|
WO2015123291A1
(en)
|
2014-02-11 |
2015-08-20 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Pcsk9 vaccine and methods of using the same
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
MA40824A
(fr)
|
2014-10-22 |
2017-08-29 |
Saiba Gmbh |
Particules de cmv de type virus modifié
|
|
WO2016112921A1
(en)
*
|
2015-01-15 |
2016-07-21 |
University Of Copenhagen |
Virus-like particle with efficient epitope display
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
HK1255206A1
(zh)
|
2015-09-08 |
2019-08-09 |
苏黎世大学 |
抗猫过敏的组合物
|
|
EP3141600A1
(en)
|
2015-09-11 |
2017-03-15 |
Institut National de la Recherche Agronomique |
Nepovirus coat protein fusion polypeptides and their use
|
|
AU2016341529B2
(en)
|
2015-10-22 |
2023-03-30 |
Juno Therapeutics Gmbh |
Methods for culturing cells and kits and apparatus for same
|
|
MX2018004875A
(es)
|
2015-10-22 |
2018-08-01 |
Juno Therapeutics Gmbh |
Metodos para cultivar celulas y kits y aparatos para ello.
|
|
EP3365453A2
(en)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics GmbH |
Methods, kits, agents and apparatuses for transduction
|
|
EP3368068B1
(en)
|
2015-10-30 |
2020-11-18 |
University of Copenhagen |
Virus like particle with efficient epitope display
|
|
SG10201912944QA
(en)
|
2016-09-02 |
2020-02-27 |
The Usa As Represented By The Secretary |
Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
JP7339160B2
(ja)
|
2017-04-27 |
2023-09-05 |
ジュノ セラピューティクス ゲーエムベーハー |
オリゴマー粒子試薬およびその使用方法
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
US12459965B2
(en)
|
2017-10-09 |
2025-11-04 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
WO2019160866A2
(en)
|
2018-02-13 |
2019-08-22 |
Checkmate Pharmaceuticals, Inc. |
Compositions and methods for tumor immunotherapy
|
|
BR112020020479A2
(pt)
|
2018-04-09 |
2021-01-12 |
Checkmate Pharmaceuticals |
Empacotamento de oligonucleotídeos em partículas similares a vírus
|
|
JP7366057B2
(ja)
|
2018-04-19 |
2023-10-20 |
チェックメイト ファーマシューティカルズ， インコーポレイテッド |
合成ｒｉｇ－ｉ様受容体アゴニスト
|
|
US12516099B2
(en)
|
2018-08-09 |
2026-01-06 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
|
SG11202104355SA
(en)
|
2018-10-31 |
2021-05-28 |
Juno Therapeutics Gmbh |
Methods for selection and stimulation of cells and apparatus for same
|
|
CN113423718A
(zh)
*
|
2019-02-08 |
2021-09-21 |
美国政府(由卫生和人类服务部的部长所代表) |
基于纳米颗粒的流感病毒疫苗及其用途
|
|
US12377112B2
(en)
|
2019-04-17 |
2025-08-05 |
Compass Pathfinder Limited |
Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
|
|
WO2021016509A1
(en)
|
2019-07-24 |
2021-01-28 |
Unm Rainforest Innovations |
Malaria immunogen and methods for using same
|
|
JP7707161B2
(ja)
|
2019-10-23 |
2025-07-14 |
チェックメイト ファーマシューティカルズ， インコーポレイテッド |
合成ｒｉｇ－ｉ様受容体アゴニスト
|
|
WO2021178257A1
(en)
*
|
2020-03-02 |
2021-09-10 |
Unm Rainforest Innovations |
Virus-like particle vaccines for opioid drugs
|
|
EP4141110A4
(en)
|
2020-04-24 |
2025-04-09 |
Sf Biotech Laboratuvar Danismanlik Anonim Sirketi |
Method for producing particles of bacteriophages of the genus levivirus
|
|
US12240813B2
(en)
|
2020-05-19 |
2025-03-04 |
Cybin Irl Limited |
Deuterated tryptamine derivatives and methods of use
|
|
CN112285361B
(zh)
*
|
2020-09-27 |
2023-12-05 |
中国人民解放军空军军医大学 |
排除抗-cd38单克隆抗体药物对抗人球蛋白检测干扰的试剂
|
|
CN114634578B
(zh)
*
|
2020-12-15 |
2024-04-02 |
榕森生物科技(北京)有限公司 |
针对新型冠状病毒感染的疫苗组合物
|
|
CN114632148B
(zh)
*
|
2020-12-15 |
2024-08-09 |
榕森生物科技(北京)有限公司 |
病原样抗原疫苗及其制备方法
|
|
CN112480245B
(zh)
*
|
2020-12-19 |
2023-08-18 |
上海佰君生物科技有限公司 |
一种疏水性环状肽配基纯化人免疫球蛋白g的应用
|
|
WO2022218928A1
(en)
|
2021-04-12 |
2022-10-20 |
Saiba AG |
Modified virus-like particles of bacteriophage ap205
|
|
WO2022229817A1
(en)
|
2021-04-28 |
2022-11-03 |
Bavarian Nordic A/S |
Vaccines comprising virus-like particles displaying sars-cov-2 antigens and methods of use
|
|
WO2023288220A2
(en)
*
|
2021-07-12 |
2023-01-19 |
Children's Hospital Medical Center |
Differential cxcr4 expression on hematopoietic progenitor cells versus stem cells directs homing and long-term engraftment
|
|
US12121574B2
(en)
|
2021-09-28 |
2024-10-22 |
Unm Rainforest Innovations |
Malaria immunogen and methods for using same
|
|
EP4581044A1
(en)
|
2022-08-31 |
2025-07-09 |
Unm Rainforest Innovations |
Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (asc) and methods of use
|
|
EP4593874A2
(en)
|
2022-09-30 |
2025-08-06 |
Bavarian Nordic A/S |
Virus-like particles displaying sars-cov-2 antigens as booster vaccines and uses thereof
|
|
CN115819623A
(zh)
*
|
2022-12-12 |
2023-03-21 |
长春百克生物科技股份公司 |
一种重组病毒样颗粒疫苗组合物的制备及应用
|
|
EP4737572A1
(en)
*
|
2023-06-29 |
2026-05-06 |
Shenzhen Herz Life Science Technology Co., Ltd |
Preparation method for castrating ap205 virus-like particle subunit vaccine
|
|
CN116987700B
(zh)
*
|
2023-07-13 |
2024-02-20 |
杭州赛基生物科技有限公司 |
一种人白细胞介素-5重组蛋白及其制备方法
|
|
WO2025194374A1
(zh)
*
|
2024-03-20 |
2025-09-25 |
深圳赫兹生命科学技术有限公司 |
猫过敏原多肽片段及应用
|